FBIO Stock Analysis: Buy, Sell, or Hold?
FBIO - Fortress Biotech, Inc.
$3.30
0.00 (0.00%)
▲
5d:
+11.86%
30d:
+19.13%
90d:
+40.43%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 13, 2026
29d
Get Alerted When FBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called FBIO this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: FBIO shows positive signals but monitor for confirmation. Market pricing in 64.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: FBIO shows positive signals but monitor for confirmation. Market pricing in 64.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$0.60
Based on -37.5% avg growth
INTRINSIC VALUE TODAY
$0.37
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FBIO is currently trading at $3.30, which is considered extended relative to its 30-day fair value range of $2.81 to $3.16. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.5) compared to its historical average (140.5). Remarkably, the market is currently pricing in an annual earnings decline of 64.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, FBIO is in a strong downtrend. The price is approaching resistance at $3.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: FBIO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+233.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, FBIO is in a strong downtrend. The price is approaching resistance at $3.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: FBIO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+233.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.81 -
$3.16
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 233.3% below Wall St target ($11.00)
Trading Range Analysis
30-Day Trading Range
$2.81 -
$3.16
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.53
Resistance Level
$3.00
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.53
Wall Street Target
$11.00
(+233.3%)
Revenue Growth (YoY)
22.1%
Profit Margin
193.1%
Valuation Discount vs History
-64.0% cheaper
PE vs Historical
6.5 vs 140.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-64.0%
(market-implied from PE analysis)
1-Year Target
$2.97
(-10%)
2-Year Target
$2.67
(-19%)
3-Year Target
$2.41
(-27%)
3-Yr Target (if PE normalizes)
(PE: 7→141)
$51.72
(+1467%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -79.0%)
$8.02
(+143%)
Base:
(SPY PE: 6.5, Growth: -79.0%)
$2.41
(-27%)
Bear:
(PE: 5.6, Growth: -79.0%)
$2.04
(-38%)
📈
Valuation based on Current Earnings
Trailing PE: 1.02 | Current EPS (TTM): $3.23
Bull Case
$1.82
(-45%)
Analyst growth -50.0%, PE expands to 1.1
Base Case
$1.65
(-50%)
Market implied -50.0%, PE stable at 1.0
Bear Case
$2.24
(-32%)
Severe decline -20.0%, PE contracts to 0.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.5 to 140.5
Stabilization Target:
$70.95
(+2050.1%)
PE Expansion Potential:
+2050.1%
Share & Embed Analysis
Last updated: July 14, 2026 6:14 AM ET
Data refreshes hourly during market hours. Next update: 7:14 AM
Data refreshes hourly during market hours. Next update: 7:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
